SR-9009 Stenabolic Liquid

Buy SR-9009 Stenabolic Liquid Online

SR-9009 Stenabolic is a synthetic REV-ERB agonist investigated primarily in laboratory and animal research. It is studied for its effects on circadian signaling, metabolic regulation, inflammation, and exercise-related biology.

Product Information

SR-9009 interacts with REV-ERB nuclear receptors that regulate genes involved in the body's molecular clock. The liquid format represents the formulation of the compound; available research concerns SR-9009 itself rather than a clinically established liquid formulation. SR-9009, also known as Stenabolic, is studied primarily as a REV-ERB agonist in preclinical research.

How It Works

SR-9009 activates REV-ERB receptors and changes transcription of genes involved in circadian and metabolic regulation. These effects can influence energy metabolism and inflammatory signaling in experimental models.

POTENTIAL BENEFITS

1. Circadian Biology Research

REV-ERB activation provides researchers with a way to examine the molecular clock and its relationship with sleep-wake and metabolic processes.

2. Metabolic Pathway Research

SR-9009 has been investigated for effects on lipid and glucose metabolism in animal models, making it relevant to metabolic-signaling research.

3. Exercise & Muscle Research

Preclinical work has examined SR-9009 in relation to exercise tolerance and skeletal-muscle metabolic pathways.

4. Inflammation Research

Research has demonstrated effects on inflammatory signaling, including NLRP3 and cytokine-related pathways in experimental models.

Dosage

There is no established human dosage for SR-9009. Published research uses animal doses under controlled experimental conditions and does not establish an appropriate dose for humans. Formulation into a liquid does not create a validated clinical dosage.

Side Effects

Because human safety data are limited, the full adverse-effect profile is unknown. Altering REV-ERB signaling could potentially affect circadian, metabolic, cardiovascular, and inflammatory systems.

References

1. PubMed — Pharmacological targeting of REV-ERBs
2. PubMed — SR9009 and exercise/metabolic research
3. PubMed — SR9009 and inflammation
4. PubMed — SR9009 and NASH/metabolism

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.